What does this video actually claim?
Aaron Reed (@aaronw.reed) responds to a viewer question about anti-estrogen medications in the context of testosterone replacement therapy. He's recommending what he calls "a good anti-estrogen" that he's mentioned previously.
The video is light on specifics. Reed doesn't name the actual medication, dosing protocols, or explain why someone on TRT might need estrogen control. This vagueness makes fact-checking difficult, but we can examine the broader claims about anti-estrogens in TRT.
Are anti-estrogens necessary for TRT patients?
Most men on TRT don't need anti-estrogen medications, despite what many online influencers suggest. Testosterone converts to estradiol through aromatase, and some estrogen is actually beneficial for men's health.
The American Urological Association's 2018 guidelines don't recommend routine estrogen suppression for TRT patients. A 2019 study by Patel et al. in the Journal of Sexual Medicine found that estradiol levels between 20-40 pg/mL were associated with better sexual function and mood in men on TRT.
Anti-estrogens like anastrozole are typically reserved for men with estradiol levels above 50-60 pg/mL who have symptoms like gynecomastia or fluid retention. Blanket recommendations for "good anti-estrogens" oversimplify this nuanced issue.
What are the risks Reed doesn't mention?
Suppressing estrogen too aggressively can cause significant problems. Low estradiol in men is linked to decreased bone density, joint pain, and sexual dysfunction.
A 2013 study by Finkelstein et al. in the New England Journal of Medicine showed that estrogen deficiency, not just testosterone deficiency, contributed to decreased sexual desire and erectile dysfunction in men. Men with estradiol levels below 10 pg/mL experienced notable sexual and physical symptoms.
Anastrozole, the most commonly prescribed aromatase inhibitor, can crash estrogen levels if dosed incorrectly. Many TRT clinics see patients who've developed joint pain, mood issues, and ironically worse sexual function from overzealous estrogen suppression.
Reed's casual recommendation lacks the nuance this topic requires.
What should TRT patients actually know?
Estrogen management in TRT should be symptom-driven, not number-driven. Most men feel best with estradiol levels in the 20-40 pg/mL range, but some tolerate higher levels without issues.
Before reaching for anti-estrogens, consider other factors. Excess body fat increases aromatase activity, so weight loss can naturally reduce estrogen conversion. Some men benefit from splitting their testosterone dose to avoid peaks that drive excessive aromatization.
If anti-estrogens are needed, start low. Anastrozole is typically dosed at 0.25mg twice weekly, not the 1mg daily dose used for breast cancer. The goal is symptom relief, not undetectable estrogen levels. Work with a physician who understands these nuances, not someone making blanket TikTok recommendations.